DISTURBANCES OF CALCIUM AND MAGNESIUM-METABOLISM OCCUR IN MOST HYPERTHYROID PATIENTS

被引:16
作者
FORD, HC [1 ]
CROOKE, MJ [1 ]
MURPHY, CE [1 ]
机构
[1] WELLINGTON HOSP, DEPT LAB SERV, DIV CHEM PATHOL, WELLINGTON, NEW ZEALAND
关键词
D O I
10.1016/S0009-9120(89)80035-9
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:373 / 376
页数:4
相关论文
共 26 条
[21]   LONG-TERM L-THYROXINE THERAPY IS ASSOCIATED WITH DECREASED HIP BONE-DENSITY IN PREMENOPAUSAL WOMEN [J].
PAUL, TL ;
KERRIGAN, J ;
KELLY, AM ;
BRAVERMAN, LE ;
BARAN, DT .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 259 (21) :3137-3141
[22]   THE DEFECT OF INTESTINAL CALCIUM-TRANSPORT IN HYPERTHYROIDISM AND ITS RESPONSE TO THERAPY [J].
PEERENBOOM, H ;
KECK, E ;
KRUSKEMPER, HL ;
STROHMEYER, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1984, 59 (05) :936-940
[23]   SUBCLINICAL HYPERTHYROIDISM AND REDUCED BONE-DENSITY AS A POSSIBLE RESULT OF PROLONGED SUPPRESSION OF THE PITUITARY-THYROID AXIS WITH L-THYROXINE [J].
ROSS, DS ;
NEER, RM ;
RIDGWAY, EC ;
DANIELS, GH .
AMERICAN JOURNAL OF MEDICINE, 1987, 82 (06) :1167-1170
[24]  
SHAFER RB, 1972, GASTROENTEROLOGY, V63, P235
[25]   INTESTINAL CALCIUM-ABSORPTION IN HYPERTHYROIDISM [J].
SINGHELAKIS, P ;
ALEVIZAKI, CC ;
IKKOS, DG .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1974, 23 (04) :311-321
[26]  
Smith D A, 1973, Clin Endocrinol Metab, V2, P333, DOI 10.1016/S0300-595X(73)80047-7